CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
56 hedge funds and large institutions have $37.3M invested in Carisma Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.09% more ownership
Funds ownership: 0.98% → 1.07% (+0.09%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
54% less call options, than puts
Call options by funds: $80K | Put options by funds: $174K
Holders
56
Holding in Top 10
1
Calls
$80K
Puts
$174K
Top Buyers
| 1 | +$1.61M | |
| 2 | +$1.21M | |
| 3 | +$860K | |
| 4 |
Two Sigma Advisers
New York
|
+$781K |
| 5 |
Morgan Stanley
New York
|
+$592K |
Top Sellers
| 1 | -$408K | |
| 2 | -$274K | |
| 3 | -$152K | |
| 4 |
Jane Street
New York
|
-$125K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$95.7K |